# ABB Ltd: Form 20-F for the period ended Dec 31, 2021

- Company: [ABB Ltd](/companies/abbny.md) (CIK 1091587)
- Form: 20-F
- Filed: 2022-02-25
- Accepted by EDGAR: Feb 24, 2022, 13:03 ET
- Period: 2021-12-31
- Accession: 0001104659-22-026793
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1091587/000110465922026793/abb20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091587/000110465922026793/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $28.95bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $19.48bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | $9.47bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $1.22bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2021-01-01 to 2021-12-31 | $5.16bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | $5.72bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $1.06bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | $4.65bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | $2.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | $2.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 2,019,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $3.33bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $820.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months, 2021-01-01 to 2021-12-31 | $1.73bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2021-01-01 to 2021-12-31 | $3.71bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-12-31 | $4.16bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $18.70bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $40.26bn | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $15.57bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $24.30bn | us-gaap:Liabilities |
| Long-term debt | at 2021-12-31 | $4.18bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-12-31 | $1.31bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2021-12-31 | $78.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2021-12-31 | $15.58bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2021-12-31 | 1,958,344,400 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091587/000110465922026793/abb20211231.htm

Filed Feb 25, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-026793. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.